Wolfgang Friess
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wolfgang Friess has a total of 206 co-authors. Here are the top co-authors by number of shared publications:
Karoline Bechtold-Peters
14 shared publicationsHanns-Christian Mahler
F. Hoffmann-La Roche Ltd, Pharmaceutical Development & Supplies, PTD Biologics Europe, Basel, Switzerland
8 shared publicationsJulia Matilainen
F. Hoffmann-La Roche Ltd, Pharmaceutical Development & Supplies, PTD Biologics Europe, Basel, Switzerland
7 shared publications- Natalie Deiringer
BASF SE Ludwigshafen Am Rhein Germany
5 shared publications Bernhard Hauptmeier
Novaliq GmbH, Im Neuenheimer Feld 515, D-69120 Heidelberg, Germany; Boehringer Ingelheim, Vetmedica GmbH, Binger Straße 173, D-55216 Ingelheim am Rhein, Germany
4 shared publicationsEduard Trenkenschuh
Department of Pharmacy–Center for Drug Research, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximillians University of Munich, Munich, Germany
4 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (11)
Verification of novel CFD-based scale-down devices against 5 L bottles for freezing and thawing of protein drug substance: Thermal histories, concentration shifts, ice-liquid interfacial area, and stability prediction
- 23 September 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (11)
Open AccessVerification of novel CFD-based scale-down devices against 5 L bottles for freezing and thawing of protein drug substance: Thermal histories, concentration shifts, ice-liquid interfacial area, and stability prediction
- 14 September 2026
- Published by Springer Nature
- p. 781-795
Freeze-Drying of Proteins
- Open Access
- 20 May 2026
- Published by Elsevier in International Journal of Pharmaceutics: X
- Vol. 11, 100572
The colder, the better? Sustainability in frozen storage of a monoclonal antibody drug substance
- 20 May 2026
- Published by Elsevier in International Journal of Pharmaceutics: X
- Vol. 11, 100572
Open AccessThe colder, the better? Sustainability in frozen storage of a monoclonal antibody drug substance
- 5 May 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (8) , 104316
Dissolved oxygen effects on human growth hormone stability during freeze-thaw and metal-catalyzed oxidation
- 5 May 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (8) , 104316
Dissolved oxygen effects on human growth hormone stability during freeze-thaw and metal-catalyzed oxidation
- Open Access
- 21 March 2026
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 223, 115052
Emerging technologies and scientific advances in lyophilization of pharmaceuticals: insights from the 2025 freeze-drying of pharmaceuticals & biologicals conference
- 21 March 2026
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 223, 115052
Open AccessEmerging technologies and scientific advances in lyophilization of pharmaceuticals: insights from the 2025 freeze-drying of pharmaceuticals & biologicals conference
- Open Access
- 3 March 2026
- Published by Elsevier in SSRN Electronic Journal
New insights into the intrinsic tryptophan fluorescence emission spectra of IgG antibodies and the impact of protein unfolding and aggregation
Intrinsic tryptophan (Trp) fluorescence emission (ITFE) spectroscopy is widely used in biologics development, yet interpretation remains challenging for proteins with more than one Trp, such as antibodies, and is often limited to bulk spectral shifts. For better understanding and more detailed characterization of mAbs by ITFE, we analyzed an in-house IgG1 therapeutic (mAbT) and the National Institute of Standards and Technology (NIST mAb) reference IgG1. Human serum albumin (HSA) was used as a single-Trp protein control. Steady-state, second-derivative and time-resolved fluorescence measurements combined with Molecular Dynamics simulations enabled site-resolved interpretation of ITFE signals. A limited number of dominant Trp residues, primarily near the complementary-determining regions (CDRs) in the VH domains, were identified as the main contributors to the overall emission. Long fluorescence lifetimes (>5 ns) correlated with moderate solvent accessibility (around 25%) and low quenching propensity. The direction of spectral shifts during unfolding and aggregation was governed by the environment of the individual VH-domain Trp. The increase in fluorescence intensity during denaturation was primarily attributed to unfolding and was further enhanced by thermal stress induced aggregation. Protein aggregation induced by interfacial stress produced similar spectral signatures in mAbT and HSA, indicating comparable effects on ITFE. This study demonstrates that integration of ITFE with molecular dynamic simulations allows for mechanistic interpretation beyond just an empirical description. By thoroughly interpreting ITFE spectra, one can obtain information about spectral properties of variable Trps residues in IgG1 molecules and gain valuable insights into protein denaturation mechanisms.
- 3 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessNew insights into the intrinsic tryptophan fluorescence emission spectra of IgG antibodies and the impact of protein unfolding and aggregation
Intrinsic tryptophan (Trp) fluorescence emission (ITFE) spectroscopy is widely used in biologics development, yet interpretation remains challenging for proteins with more than one Trp, such as antibodies, and is often limited to bulk spectral shifts. For better understanding and more detailed characterization of mAbs by ITFE, we analyzed an in-house IgG1 therapeutic (mAbT) and the National Institute of Standards and Technology (NIST mAb) reference IgG1. Human serum albumin (HSA) was used as a single-Trp protein control. Steady-state, second-derivative and time-resolved fluorescence measurements combined with Molecular Dynamics simulations enabled site-resolved interpretation of ITFE signals. A limited number of dominant Trp residues, primarily near the complementary-determining regions (CDRs) in the VH domains, were identified as the main contributors to the overall emission. Long fluorescence lifetimes (>5 ns) correlated with moderate solvent accessibility (around 25%) and low quenching propensity. The direction of spectral shifts during unfolding and aggregation was governed by the environment of the individual VH-domain Trp. The increase in fluorescence intensity during denaturation was primarily attributed to unfolding and was further enhanced by thermal stress induced aggregation. Protein aggregation induced by interfacial stress produced similar spectral signatures in mAbT and HSA, indicating comparable effects on ITFE. This study demonstrates that integration of ITFE with molecular dynamic simulations allows for mechanistic interpretation beyond just an empirical description. By thoroughly interpreting ITFE spectra, one can obtain information about spectral properties of variable Trps residues in IgG1 molecules and gain valuable insights into protein denaturation mechanisms.
- 19 May 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 212, 107131
Editorial: Honoring Prof. Gerhard Winter with the LMU Winter-Workshop special issue
- 19 May 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 212, 107131
Editorial: Honoring Prof. Gerhard Winter with the LMU Winter-Workshop special issue
- Open Access
- 10 March 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 209, 107068
Enhancing Martini 3 for protein self-interaction simulations
- 10 March 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 209, 107068
Open AccessEnhancing Martini 3 for protein self-interaction simulations